Garcia HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH, 2005. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 72: 3–9.
Serpa JA, Yancey LS, White AC Jr, 2006. Advances in the diagnosis and management of neurocysticercosis. Expert Rev Anti Infect Ther 4: 1051–1061.
Garcia HH, Del Brutto OH, 2005. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4: 653–661.
Alarcon F, Hidalgo F, Moncayo J, Vinan I, Duenas G, 1992. Cerebral cysticercosis and stroke. Stroke 23: 224–228.
Soto-Hernandez JL, Gomez-Llata Andrade S, Rojas-Echeverri LA, Texeira F, Romero V, 1996. Subarachnoid hemorrhage secondary to a ruptured inflammatory aneurysm: a possible manifestation of neurocysticercosis: case report. Neurosurgery 38: 197–199, discussion 9–200.
Huang PP, Choudhri HF, Jallo G, Miller DC, 2000. Inflammatory aneurysm and neurocysticercosis: further evidence for a causal relationship? Case report. Neurosurgery 47: 466–467, discussion 7–8.
Tellez-Zenteno JF, Negrete-Pulido O, Cantu C, Marquez C, Vega-Boada F, Garcia Ramos G, 2003. Hemorrhagic stroke associated to neurocysticercosis. Neurologia 18: 272–275.
Kim IY, Kim TS, Lee JH, Lee MC, Lee JK, Jung S, 2005. Inflammatory aneurysm due to neurocysticercosis. J Clin Neurosci 12: 585–588.
Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proano JV, Takayanagui OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia HH, 2006. Treatment of neurocysticercosis: current status and future research needs. Neurology 67: 1120–1127.
Zee CS, Segall HD, Miller C, Tsai FY, Teal JS, Hieshima G, Ahmadi J, Halls J, 1980. Unusual neuroradiological features of intracranial cysticercosis. Radiology 137: 397–407.
Iwanowski L, Wislawski J, 1987. Neuropathologic analysis of 8 undiagnosed cases of cerebral cysticercosis. Neurol Neurochir Pol 21: 390–395.
Sawhney IM, Singh G, Lekhra OP, Mathuriya SN, Parihar PS, Prabhakar S, 1998. Uncommon presentations of neurocysticercosis. J Neurol Sci 154: 94–100.
Barinagarrementeria F, Cantu C, 1998. Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study. Stroke 29: 123–125.
Rodriguez S, Dorny P, Tsang VC, Pretell EJ, Brandt J, Lescano AG, Gonzalez AE, Gilman RH, Garcia HH, 2009. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis 199: 1345–1352.
|Past two years||Past Year||Past 30 Days|
|Full Text Views||335||130||5|
Cerebrovascular complications have been reported to occur in patients with neurocysticercosis (NCC). We report a patient who presented with relapsed subarachnoid hemorrhage possibly linked to NCC. In addition, we performed a literature review of all of the reported cases of aneurysmal and non-aneurysmal hemorrhagic cerebrovascular events associated with NCC. We identified 11 such cases. The majority of the individuals were young males (mean: 38 years; 70% males). Four cases (36%) had aneurysms. Four (36%) others had negative cerebral angiograms and therefore classified as non-aneurysmal, while the remaining three (28%) did not report sufficient information to classify them. All cases with aneurysmal hemorrhage underwent successful surgical repair of the aneurysms. Seven patients received albendazole (including three who had had surgery). Three patients died; all three presented in the pre-albendazole era. In summary, neurocysticercosis should be considered in the differential diagnosis of hemorrhagic cerebrovascular events in young patients without classical vascular risk factors who have lived or visited NCC-endemic areas.
Authors' addresses: George M. Viola, The University of Texas MD Anderson Cancer Center, Department of Medicine, Division of Infectious Diseases, Infection Control and Employee Health, Houston, TX, E-mail: GMViola@mdanderson.org. A. Clinton White Jr., Director, Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, E-mail: firstname.lastname@example.org. Jose A. Serpa, Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, E-mail: email@example.com.